Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail Carson

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Molecular Cancer Therapeutics|June 6, 2012
Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cellsWendy L Allen, Richard C Turkington, Leanne Stevenson, et al.
BMC Anesthesiology|July 14, 2016
Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physiciansYaseen M Arabi, Farhan Al-Enezi, Kajsa-Stina Longuere, et al.
Plos One|May 18, 2021
Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic reviewLakshmi Manoharan, Jonathan W S Cattrall, Carlyn Harris, et al.
BMC Medicine|September 8, 2020
Preparing for a pandemic: highlighting themes for research funding and practice-perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)Alice Norton, Louise Sigfrid, Adeniyi Aderoba, et al.
BMC Medicine|June 27, 2020
Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping reviewLouise Sigfrid, Katherine Maskell, Peter G Bannister, et al.
Eclinicalmedicine|July 18, 2025
PEARLES challenges and solutions to the implementation of clinical research responses to epidemics and pandemics: a scoping reviewBranagh Crealock-Ashurst, Shanthi Levanita, Sandrena Ruth Frischer, et al.
Molecular Cancer Therapeutics|October 27, 2011
A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancerWendy L Allen, Leanne Stevenson, Vicky M Coyle, et al.
Plos One|September 10, 2016
Experimental Treatment of Ebola Virus Disease with BrincidofovirJake Dunning, Stephen B Kennedy, Annick Antierens, et al.
Elife|November 23, 2021
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort, Matthew D Hall, Joaquín Baruch, et al.
The Lancet. Respiratory Medicine|March 7, 2021
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UKChloe I Bloom, Thomas M Drake, Annemarie B Docherty, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Molecular Cancer Therapeutics|June 6, 2012
Pharmacogenomic profiling and pathway analyses identify MAPK-dependent migration as an acute response to SN38 in p53 null and p53-mutant colorectal cancer cellsWendy L Allen, Richard C Turkington, Leanne Stevenson, et al.
BMC Anesthesiology|July 14, 2016
Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physiciansYaseen M Arabi, Farhan Al-Enezi, Kajsa-Stina Longuere, et al.
Plos One|May 18, 2021
Evaluating clinical characteristics studies produced early in the Covid-19 pandemic: A systematic reviewLakshmi Manoharan, Jonathan W S Cattrall, Carlyn Harris, et al.
BMC Medicine|September 8, 2020
Preparing for a pandemic: highlighting themes for research funding and practice-perspectives from the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)Alice Norton, Louise Sigfrid, Adeniyi Aderoba, et al.
BMC Medicine|June 27, 2020
Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping reviewLouise Sigfrid, Katherine Maskell, Peter G Bannister, et al.
Eclinicalmedicine|July 18, 2025
PEARLES challenges and solutions to the implementation of clinical research responses to epidemics and pandemics: a scoping reviewBranagh Crealock-Ashurst, Shanthi Levanita, Sandrena Ruth Frischer, et al.
Molecular Cancer Therapeutics|October 27, 2011
A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancerWendy L Allen, Leanne Stevenson, Vicky M Coyle, et al.
Plos One|September 10, 2016
Experimental Treatment of Ebola Virus Disease with BrincidofovirJake Dunning, Stephen B Kennedy, Annick Antierens, et al.
Elife|November 23, 2021
Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort, Matthew D Hall, Joaquín Baruch, et al.
The Lancet. Respiratory Medicine|March 7, 2021
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UKChloe I Bloom, Thomas M Drake, Annemarie B Docherty, et al.
Pageof 6